Bio-Rad Laboratories, Inc. (NYSE:BIO.B)’s stock price hit a new 52-week high on Monday . The stock traded as high as $331.75 and last traded at $331.75, with a volume of 100 shares trading hands. The stock had previously closed at $318.04.
Separately, ValuEngine cut Bio-Rad Laboratories from a “buy” rating to a “hold” rating in a research note on Thursday, June 6th.
The firm has a fifty day moving average of $319.89 and a two-hundred day moving average of $301.92. The company has a quick ratio of 3.36, a current ratio of 4.68 and a debt-to-equity ratio of 0.11.
About Bio-Rad Laboratories (NYSE:BIO.B)
Bio-Rad Laboratories, Inc develops, manufactures, and markets products and solutions for the life science research and clinical diagnostic markets in Europe, the Pacific Rim, the United States, and internationally. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components.
Recommended Story: Why do companies issue convertible shares?
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.